Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 5, 2025 • 7:00 PM ET

Date/Time Source News Release
11/18/2024 08:01 AM EST PR Newswire NeuroBo Pharmaceuticals Announces Strategic Realignment Ahead of Important Clinical Milestones with Name Change to MetaVia - Reflecting the Company's Focus on Cardiometabolic Diseases
11/15/2024 08:35 AM EST GlobeNewswire Life Sciences Investor Forum: Presentations Now Available for Online Viewing
11/13/2024 08:01 AM EST PR Newswire NeuroBo Pharmaceuticals to Participate in Investor Conferences in November
11/12/2024 08:35 AM EST GlobeNewswire Life Sciences Investor Forum Agenda Announced for November 14th
11/07/2024 08:01 AM EST PR Newswire NeuroBo Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/04/2024 08:01 AM EST PR Newswire NeuroBo Pharmaceuticals Completes Last Patient Last Visit in Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH
10/01/2024 08:01 AM EDT PR Newswire NeuroBo Pharmaceuticals to Participate in Investor Conferences in October
09/30/2024 08:01 AM EDT PR Newswire NeuroBo Pharmaceuticals Announces Positive Top-Line Data From the SAD Part 1 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
09/03/2024 08:01 AM EDT PR Newswire NeuroBo to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
08/14/2024 08:01 AM EDT PR Newswire NeuroBo Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Page

Additional News

As of January 5, 2025 • 7:00 PM ET

Date/Time Source News Release
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - NeuroBo Pharmaceuticals Inc.
11/07/2024 11:21 AM EST SeekingAlpha NeuroBo Pharmaceuticals GAAP EPS of -$0.55 beats by $0.18
10/11/2024 03:00 PM EDT SeekingAlpha Catalyst Watch: Netflix earnings, Lenovo tech event, Paris Motor Show, and eyes on oil
08/15/2024 11:57 AM EDT SeekingAlpha NeuroBo Pharmaceuticals GAAP EPS of -$1.85
07/30/2024 08:51 AM EDT SeekingAlpha NeuroBo Pharmaceuticals signs exclusive license agreement with Mthera Pharma
06/24/2024 02:31 PM EDT SeekingAlpha NeuroBo Pharma prices private placement and direct offering to raise up to $70M
05/30/2024 11:22 AM EDT SeekingAlpha Goldman Sachs raises obesity drug market estimate to $130B
05/22/2024 10:01 AM EDT SeekingAlpha NeuroBo says DA-1241, Wegovy combo shows potential in treating MASH
05/10/2024 05:39 AM EDT US Earnings Reports Expected earnings - NeuroBo Pharmaceuticals Inc.
05/09/2024 10:49 AM EDT SeekingAlpha NeuroBo Pharmaceuticals GAAP EPS of -$1.32
Page